Research Articles | Page 2 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Molecular pathogenesis of myelodysplastic syndromes Feb 2014 Transl Med UniSa myelodysplastic syndromes (MDS)
Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going Feb 2014 Transl Med UniSa paroxysmal nocturnal hemoglobinuria (PNH)
The dysfunction of platelets in paroxysmal nocturnal hemoglobinuria Jul 2016 Thromb Res paroxysmal nocturnal hemoglobinuria (PNH)
Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study Jan 2017 Thromb Res aplastic anemia
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study Oct 2020 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria Sep 2019 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis Dec 2023 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Treatment options for lower-risk myelodysplastic syndromes. Where are we now? Jan 2021 Therapeutic Advances in Hematology myelodysplastic syndromes (MDS)
Management of myelodysplastic syndromes after failure of response to hypomethylating agents May 2019 Therapeutic Advances in Hematology myelodysplastic syndromes (MDS)
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations Aug 2016 Ther Clin Risk Manag paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.